Biotechnology - Asia-Pacific, Pfizer

Filter

Current filters:

Asia-PacificPfizer

Popular Filters

Pfizer and Biocon cancel biosimilars deal

14-03-2012

Indian biotech firm Biocon (BSE: 532523) and global drugs behemoth Pfizer (NYSE: PFE) yesterday announced…

Asia-PacificBioconBiotechnologyDiabetesInsulinLicensingNovo NordiskPfizerPharmaceutical

Company Spotlight

ImmunoGen

ImmunoGen

Back to top